Skip to main content
Premium Trial:

Request an Annual Quote

InforSense, Ingenuity Announce Pathway-Analysis Alliance

NEW YORK (GenomeWeb News) — InforSense and Ingenuity today said that customers who have licensed InforSense’s KDE platform and Igenuity’s IPA pathways-analysis software will be able to use newly developed IPA nodes along with their existing KDE workflows.

InforSense said this will enable customers to “enhance and expand” IPA functions and allow them to view genetic information taken from a KDE workflow.

Ingenuity Systems has also joined the InforSense Open Workflow Partner Network.

The IPA nodes are available through InforSense, the company said.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.